# Facial Thermography Study of Levocetirizine Versus Cetirizine

> **NCT00150761** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 60 (—)

## Conditions studied

- Anti-allergic Agents

## Interventions

- **DRUG:** Levocetirizine (drug)

## Key facts

- **NCT ID:** NCT00150761
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 60 (—)
- **Last updated:** 2014-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150761, "Facial Thermography Study of Levocetirizine Versus Cetirizine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00150761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*